date:Jan 17, 2013
nce Products segment, which includes the Nutrition Health division. We believe that our offer represents the full and fair value to all shareholders and that it provides the best solution for Pronovas stakeholders.
All regulatory approvals required for completion of the voluntary offer have been obtained. The offer is subject to fulfillment of all further relevant offer conditions, set out in the offer document published on Dec. 5, 2012, including inter alia that shareholders shall in the aggr